+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Emphysema Treatment Market - Global Forecast 2026-2032- Product Image
Emphysema Treatment Market - Global Forecast 2026-2032- Product Image
New

Emphysema Treatment Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 184 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6015346
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Emphysema Treatment Market is shaped by ongoing innovation across pharmacological, surgical, and digital care modalities, while health system priorities continuously evolve. Senior leaders seeking clarity amid therapeutic diversity, regulatory change, and supply chain volatility will find forward-focused insights and actionable frameworks in this executive analysis.

Market Snapshot: Emphysema Treatment Market Growth

Between 2025 and 2026, the Emphysema Treatment Market expanded from USD 7.32 billion to USD 7.84 billion. Industry forecasts anticipate sustained compound annual growth, with market value projected to approach USD 11.94 billion by 2032. This upward trend reflects shifts in therapeutic adoption, device uptake, and evolving healthcare delivery approaches.

Scope & Segmentation

  • Treatment Types: Includes pharmacological therapies (antibiotics, bronchodilators, corticosteroids, mucolytics) and surgical/ device-based procedures (bullectomy, transplantation, lung volume reduction, valve therapy).
  • Drug Classes: Segments such as anticholinergics, beta-agonists, and advanced combination therapies inform clinical decision-making and comparative effectiveness.
  • Therapy Lines: Covers adjunctive, first-line, maintenance, and rescue protocols to map care pathways and intervention milestones.
  • Administration Routes: Encompasses inhalers (dry powder, metered dose, soft mist), nebulizers, intravenous infusions, injectables, and oral forms (capsules, solutions, tablets).
  • Dosage Forms & Distribution Channels: Primary formats include inhalers, nebulizers, capsules, tablets, and solutions—distributed through hospital, online, and retail pharmacies.
  • Product Types: Both branded and generic formulations, supporting diverse pricing and lifecycle management strategies.
  • Regions: Analysis spans Americas, Europe, Middle East & Africa, and Asia-Pacific, addressing localized regulatory frameworks, clinical infrastructure, and procurement models.
  • Technology Integration: Assesses advances in digital health, patient monitoring, and device engineering that underpin emerging care pathways.

Key Takeaways & Strategic Insights

  • Therapeutic approaches are diversifying, with innovation spanning not only pharmacological agents but also precise device technologies and minimally invasive surgical options.
  • Value-based reimbursement and payer expectations are increasingly central, influencing adoption decisions and commercial models for both drugs and devices.
  • Digital health solutions, including remote monitoring and patient engagement tools, are improving adherence and enabling clinicians to detect and address exacerbations proactively.
  • Supply chain governance is under greater scrutiny from both tariffs and logistical pressures, prompting industry to revisit sourcing strategies and build greater channel resilience.
  • Regional differences in regulation, healthcare infrastructure, and economic resources demand tailored market access and commercial strategies, with localized evidence generation playing a critical role.
  • Collaboration between manufacturers, providers, and payers is leading to integrated care models and concentrated centers of excellence aimed at improving clinical outcomes.

Tariff Impact on Supply Chain and Pricing Strategy

Recent United States tariff policies have introduced complexity into procurement and distribution for devices and key pharmaceutical components. Manufacturers are diversifying global sourcing, increasing local production where feasible, and negotiating longer supply contracts to secure continuity. Healthcare systems are moderating costs while maintaining patient access, fostering closer payer-manufacturer collaborations to stabilize pricing and support ongoing innovation.

Methodology & Data Sources

Analysis is grounded in a combination of peer-reviewed clinical literature, regulatory updates, commercial filings, and qualitative interviews with pulmonologists, surgeons, and healthcare pharmacists. Triangulation of these sources ensures findings are validated, actionable, and relevant to senior decision-makers.

Why This Report Matters

  • Enables executive teams to align R&D and commercialization with actual clinical priorities, health system pressures, and payer value frameworks.
  • Offers visibility into emerging technologies, regulatory pathways, and supply chain disruptions that may alter investment or partnership strategies.
  • Empowers organizations to benchmark segmentation strategies and adapt to regional variations, supporting better positioning for market access and institutional partnerships.

Conclusion

The path forward for emphysema treatment leadership lies in integration—of clinical evidence, robust delivery models, and resilient, adaptable supply strategies. Strategic focus on patient need, innovation, and regional adaptability will drive sustainable competitive advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Emphysema Treatment Market, by Treatment Type
8.1. Pharmacological
8.1.1. Antibiotics
8.1.2. Bronchodilators
8.1.3. Corticosteroids
8.1.4. Mucolytics
8.2. Surgical
8.2.1. Bullectomy
8.2.2. Lung Transplantation
8.2.3. Lung Volume Reduction Surgery
8.2.4. Valve Therapy
9. Emphysema Treatment Market, by Drug Class
9.1. Anticholinergics
9.2. Beta-Agonists
9.3. Combination Drugs
10. Emphysema Treatment Market, by Therapy Line
10.1. Adjunctive
10.2. First-Line
10.3. Maintenance
10.3.1. Combination Therapy
10.3.2. Long-Acting Anticholinergics
10.3.3. Long-Acting Beta-Agonists
10.4. Rescue
10.4.1. Short-Acting Anticholinergics
10.4.2. Short-Acting Beta-Agonists
11. Emphysema Treatment Market, by Route Of Administration
11.1. Inhalation
11.1.1. Dry Powder Inhaler
11.1.2. Metered Dose Inhaler
11.1.3. Nebulizer
11.1.4. Soft Mist Inhaler
11.2. Intravenous
11.2.1. Infusion
11.2.2. Injection
11.3. Oral
11.3.1. Capsule
11.3.2. Solution
11.3.3. Tablet
12. Emphysema Treatment Market, by Dosage Form
12.1. Capsule
12.2. Inhaler
12.3. Nebulizer
12.4. Solution
12.5. Tablet
13. Emphysema Treatment Market, by Product Type
13.1. Brand
13.2. Generic
14. Emphysema Treatment Market, by Distribution Channel
14.1. Hospital Pharmacy
14.2. Online Pharmacy
14.3. Retail Pharmacy
15. Emphysema Treatment Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific
16. Emphysema Treatment Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Emphysema Treatment Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. United States Emphysema Treatment Market
19. China Emphysema Treatment Market
20. Competitive Landscape
20.1. Market Concentration Analysis, 2025
20.1.1. Concentration Ratio (CR)
20.1.2. Herfindahl Hirschman Index (HHI)
20.2. Recent Developments & Impact Analysis, 2025
20.3. Product Portfolio Analysis, 2025
20.4. Benchmarking Analysis, 2025
20.5. Amgen Inc.
20.6. Astellas Pharma Inc.
20.7. AstraZeneca plc
20.8. Baxter International Inc.
20.9. Boehringer Ingelheim International GmbH
20.10. Boston Scientific Corporation
20.11. Chiesi Farmaceutici S.p.A.
20.12. Cipla Limited
20.13. GlaxoSmithKline plc
20.14. Grifols S.A.
20.15. Johnson & Johnson Services, Inc.
20.16. Merck & Co., Inc.
20.17. Mylan N.V.
20.18. Novartis AG
20.19. Olympus Corporation
20.20. Orion Corporation
20.21. Pfizer, Inc.
20.22. Pulmonx Corporation
20.23. ResMed, Inc.
20.24. Roche Holding AG
20.25. Sandoz International GmbH
20.26. Sanofi S.A.
20.27. Sunovion Pharmaceuticals Inc.
20.28. Teva Pharmaceutical Industries Ltd
20.29. Theravance Biopharma, Inc.
20.30. Verona Pharma plc
20.31. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL EMPHYSEMA TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL EMPHYSEMA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 15. CHINA EMPHYSEMA TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BRONCHODILATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BRONCHODILATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MUCOLYTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MUCOLYTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MUCOLYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BULLECTOMY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BULLECTOMY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BULLECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LUNG TRANSPLANTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LUNG TRANSPLANTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LUNG TRANSPLANTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LUNG VOLUME REDUCTION SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LUNG VOLUME REDUCTION SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LUNG VOLUME REDUCTION SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY VALVE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY VALVE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY VALVE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ANTICHOLINERGICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ANTICHOLINERGICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BETA-AGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BETA-AGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BETA-AGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COMBINATION DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COMBINATION DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COMBINATION DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ADJUNCTIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ADJUNCTIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ADJUNCTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY FIRST-LINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY FIRST-LINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY FIRST-LINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LONG-ACTING ANTICHOLINERGICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LONG-ACTING ANTICHOLINERGICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LONG-ACTING ANTICHOLINERGICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LONG-ACTING BETA-AGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LONG-ACTING BETA-AGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LONG-ACTING BETA-AGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SHORT-ACTING ANTICHOLINERGICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SHORT-ACTING ANTICHOLINERGICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SHORT-ACTING ANTICHOLINERGICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SHORT-ACTING BETA-AGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SHORT-ACTING BETA-AGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SHORT-ACTING BETA-AGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DRY POWDER INHALER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DRY POWDER INHALER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY METERED DOSE INHALER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY METERED DOSE INHALER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY NEBULIZER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY NEBULIZER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SOFT MIST INHALER, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SOFT MIST INHALER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SOFT MIST INHALER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INFUSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INFUSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALER, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY NEBULIZER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY NEBULIZER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BRAND, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BRAND, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BRAND, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 150. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 151. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 152. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 153. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 154. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 155. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2032 (USD MILLION)
TABLE 156. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2032 (USD MILLION)
TABLE 157. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 158. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 159. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 160. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 161. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 162. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 163. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 170. NORTH AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2032 (USD MILLION)
TABLE 171. NORTH AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2032 (USD MILLION)
TABLE 172. NORTH AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 173. NORTH AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 174. NORTH AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 175. NORTH AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 176. NORTH AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 177. NORTH AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 178. NORTH AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 182. LATIN AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 183. LATIN AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 184. LATIN AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 185. LATIN AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2032 (USD MILLION)
TABLE 186. LATIN AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2032 (USD MILLION)
TABLE 187. LATIN AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 188. LATIN AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 189. LATIN AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 190. LATIN AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 191. LATIN AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 192. LATIN AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 193. LATIN AMERICA EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2032 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2032 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 209. EUROPE EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. EUROPE EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 211. EUROPE EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 212. EUROPE EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 213. EUROPE EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 214. EUROPE EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 215. EUROPE EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2032 (USD MILLION)
TABLE 216. EUROPE EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2032 (USD MILLION)
TABLE 217. EUROPE EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 218. EUROPE EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 219. EUROPE EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 220. EUROPE EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 221. EUROPE EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 222. EUROPE EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 223. EUROPE EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 224. MIDDLE EAST EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 225. MIDDLE EAST EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 226. MIDDLE EAST EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 227. MIDDLE EAST EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 228. MIDDLE EAST EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 229. MIDDLE EAST EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 230. MIDDLE EAST EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2032 (USD MILLION)
TABLE 231. MIDDLE EAST EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2032 (USD MILLION)
TABLE 232. MIDDLE EAST EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 233. MIDDLE EAST EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 234. MIDDLE EAST EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 235. MIDDLE EAST EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 236. MIDDLE EAST EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 237. MIDDLE EAST EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 238. MIDDLE EAST EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 239. AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 240. AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 241. AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 242. AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 243. AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 244. AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 245. AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2032 (USD MILLION)
TABLE 246. AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2032 (USD MILLION)
TABLE 247. AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 248. AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 249. AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 250. AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 251. AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 252. AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 253. AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 254. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 255. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 256. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 257. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 258. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 259. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 260. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2032 (USD MILLION)
TABLE 261. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2032 (USD MILLION)
TABLE 262. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 263. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 264. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 265. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 266. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 267. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 268. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 269. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 270. ASEAN EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 271. ASEAN EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 272. ASEAN EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 273. ASEAN EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 274. ASEAN EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 275. ASEAN EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 276. ASEAN EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2032 (USD MILLION)
TABLE 277. ASEAN EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2032 (USD MILLION)
TABLE 278. ASEAN EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 279. ASEAN EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 280. ASEAN EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 281. ASEAN EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 282. ASEAN EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 283. ASEAN EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 284. ASEAN EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 285. GCC EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 286. GCC EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 287. GCC EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 288. GCC EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 289. GCC EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 290. GCC EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 291. GCC EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2032 (USD MILLION)
TABLE 292. GCC EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2032 (USD MILLION)
TABLE 293. GCC EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 294. GCC EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 295. GCC EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 296. GCC EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 297. GCC EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 298. GCC EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 299. GCC EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 300. EUROPEAN UNION EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 301. EUROPEAN UNION EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 302. EUROPEAN UNION EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 303. EUROPEAN UNION EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 304. EUROPEAN UNION EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 305. EUROPEAN UNION EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 306. EUROPEAN UNION EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2032 (USD MILLION)
TABLE 307. EUROPEAN UNION EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2032 (USD MILLION)
TABLE 308. EUROPEAN UNION EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 309. EUROPEAN UNION EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 310. EUROPEAN UNION EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 311. EUROPEAN UNION EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 312. EUROPEAN UNION EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 313. EUROPEAN UNION EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 314. EUROPEAN UNION EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 315. BRICS EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 316. BRICS EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 317. BRICS EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 318. BRICS EMPHYSEMA TREATMENT MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 319. BRICS EMPHYSEMA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 320. BRICS EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 321. BRICS EMPHYSEMA TREATMENT MARKET SIZE, BY MAINTENANCE, 2018-2032 (USD MILLION)
TABLE 322. BRICS EMPHYSEMA TREATMENT MARKET SIZE, BY RESCUE, 2018-2032 (USD MILLION)
TABLE 323. BRICS EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 324. BRICS EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 325. BRICS EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 326. BRICS EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 327. BRICS EMPHYSEMA TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 328. BRICS EMPHYSEMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 329. BRICS EMPHYSEMA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 330. G7 EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 331. G7 EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 332. G7 EMPHYSEMA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 333. G7 EMPHYSEMA TREATMENT MARKET SIZE, BY SURGI

Companies Mentioned

The key companies profiled in this Emphysema Treatment market report include:
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Baxter International Inc.
  • Boehringer Ingelheim International GmbH
  • Boston Scientific Corporation
  • Chiesi Farmaceutici S.p.A.
  • Cipla Limited
  • GlaxoSmithKline plc
  • Grifols S.A.
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Olympus Corporation
  • Orion Corporation
  • Pfizer, Inc.
  • Pulmonx Corporation
  • ResMed, Inc.
  • Roche Holding AG
  • Sandoz International GmbH
  • Sanofi S.A.
  • Sunovion Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd
  • Theravance Biopharma, Inc.
  • Verona Pharma plc
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages184
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 7.84 Billion
Forecasted Market Value ( USD ) by 2032 $ 11.94 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Emphysema Treatment Market Report 2025 - Product Image

Emphysema Treatment Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Emphysema Treatment Medication Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Emphysema Treatment Medication Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Emphysema Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Emphysema Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 135 Pages
  • Global
From
Emphysema Treatment Market Size Analysis Report - Market Share, Forecast Trends and Outlook (2025-2034) - Product Image

Emphysema Treatment Market Size Analysis Report - Market Share, Forecast Trends and Outlook (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Emphysema Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Emphysema Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From

About the Emphysema Drug Market

The Emphysema Drug market is a subset of the larger Respiratory Drugs market. It is composed of drugs used to treat emphysema, a chronic lung disease that causes shortness of breath, coughing, and wheezing. These drugs are typically inhaled corticosteroids, bronchodilators, and phosphodiesterase-4 inhibitors. They are used to reduce inflammation, open airways, and improve breathing. The Emphysema Drug market is highly competitive, with many companies offering similar products. Some of the major players in the market include GlaxoSmithKline, AstraZeneca, Novartis, Merck, and Boehringer Ingelheim. Other companies, such as Sunovion, Teva Pharmaceuticals, and Mylan, also offer products in this market. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.